Background
Founded in 2018, NOVI Health is a Singapore-based health-tech company specializing in technology-enhanced clinical solutions for personalized health, diabetes, and metabolic disease management. The company's mission is to empower individuals to live free from the burden of diabetes and other chronic weight and lifestyle-related conditions by integrating precision medicine with behavioral and lifestyle interventions. NOVI Health's vision is to enhance clinical care through holistic, personalized approaches, leveraging deep human expertise and data insights to achieve better health outcomes.
Key Strategic Focus
NOVI Health's strategic focus centers on providing hyper-personalized, holistic health solutions that integrate clinical treatments with behavioral and lifestyle interventions. The company specializes in managing metabolic disorders such as diabetes, high blood pressure, high cholesterol, and obesity. By leveraging technology-enabled platforms, NOVI Health aims to address the root causes of chronic conditions, offering services that are both accessible and affordable.
Financials and Funding
In November 2022, NOVI Health secured $5 million in a Series A funding round led by Monk’s Hill Ventures. The capital is intended to accelerate hiring for technology, growth, and product teams, as well as to further invest in the company's technology-enabled platform.
Pipeline Development
NOVI Health offers two core digital products:
- NOVI Magnum: Designed for individuals with diabetes, this program combines continuous glucose monitoring technology with medical care and dietary and lifestyle coaching to optimize diabetes control. A study indicated that participants reduced their HbA1c levels by 0.9 points and weight by 5.8% over a three-month period without an increase in medication.
- NOVI Optimum Plus: Targeted at individuals with excess weight, this program integrates validated medical treatment with health coaching to achieve sustainable and healthy weight loss.
Technological Platform and Innovation
NOVI Health's technological platform is distinguished by its integration of precision medicine with behavioral and lifestyle interventions. The company's digital-first approach enhances accessibility and affordability, allowing for scalable impact. By leveraging continuous glucose monitoring technology and data-driven insights, NOVI Health provides real-time, actionable feedback to clients, facilitating personalized and effective health management strategies.
Leadership Team
- Dr. Sue Anne Toh: Co-Founder, Chief Executive Officer, and Medical Director. Dr. Toh leads NOVI Health with a vision to empower individuals to live free from chronic conditions through holistic and personalized healthcare solutions.
- Dr. Joanne Tay: Co-Founder and Chief Operating Officer. Dr. Tay oversees the company's operations, ensuring the seamless delivery of NOVI Health's services.
- Dr. Kyle Tan: Co-Founder and Chief Product and Business Development Officer. Dr. Tan focuses on product innovation and business growth strategies.
- Peter Wong: Chief Technology Officer. Wong leads the technological development and implementation of NOVI Health's platforms.
Leadership Changes
In conjunction with the Series A funding round, NOVI Health appointed Peng T. Ong, Co-Founder and Managing Partner at Monk’s Hill Ventures, and Edwin Chan, a current Carousell Group and former Razer executive, as directors on its board.
Competitor Profile
Market Insights and Dynamics
The global prevalence of chronic conditions such as diabetes and obesity underscores the significant demand for effective management solutions. In 2021, diabetes was responsible for 6.7 million deaths worldwide, highlighting the urgent need for innovative healthcare interventions.
Competitor Analysis
Key competitors in the chronic disease management space include:
- Omada Health: A San Francisco-based company offering digital behavioral medicine programs for chronic disease prevention and management.
- Welldoc: A Columbia, Maryland-based digital health company providing solutions for chronic disease management, including diabetes.
These competitors focus on integrating digital health solutions with behavioral interventions to manage chronic conditions, similar to NOVI Health's approach.
Strategic Collaborations and Partnerships
In January 2025, NOVI Health partnered with MyOme, Inc., a whole genomic analysis and polygenic risk modeling company, to enhance personalized and preventive healthcare offerings.
Operational Insights
NOVI Health's digital-first approach and integration of precision medicine with behavioral interventions position the company to effectively address the root causes of chronic conditions. This strategy enhances accessibility and affordability, providing a distinct competitive advantage in the chronic disease management market.
Strategic Opportunities and Future Directions
With the recent Series A funding, NOVI Health plans to accelerate hiring for its technology, growth, and product teams, and to further invest in its technology-enabled platform. These initiatives aim to expand the company's reach and impact, addressing the significant unmet needs in chronic disease management.
Contact Information
- Website: novi-health.com
- LinkedIn: linkedin.com/company/novi-health
- Headquarters: Singapore
